Cite
MLA Citation
Shuta Ohara et al.. “Dose-dependence in acquisition of drug tolerant phenotype and high RYK expression as a mechanism of osimertinib tolerance in lung cancer.” Lung cancer, vol. 154, 2021, pp. 84–91. http://access.bl.uk/ark:/81055/vdc_100124369039.0x000040